Notas del episodio
What if our immune cells could be reprogrammed to sense, decide and act—outsmarting even the most elusive tumors?
In this episode of From Bench to Fireside Kole Roybal, PhD, Director of the Parker Institute of Cancer Immunotherapy Center at UCSF, joins PICI Chief Scientific Officer John Connolly, PhD, to break down how engineered immune cells are moving from the lab to the clinic—and changing how we approach solid tumors. They discuss how technologies like SynNotch and SNIPR are giving immune cells programmable intelligence—and how PICI’s collaborative model helped accelerate these innovations from discovery to patient-ready therapies.
Along the way, Dr. Roybal reflects on mentorship, team-building and how engineered immunity could reshape medicine far beyond cancer.
—
From Bench to Fireside™ is a po ...